Laura B. Kirwan

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Performance Evaluation of a Novel Cystic Fibrosis Caregiver Burden Measure Demonstrates Significant Challenges for Parents of Children With CF During the Early Years: The Irish Comparative Outcomes Study (ICOS).

Performance Evaluation of a Novel Cystic Fibrosis Caregiver Burden Measure Demonstrates Significant Challenges for Parents of Children With CF During the Early Years: The Irish Comparative Outcomes Study (ICOS).

Journal: Pediatric pulmonology

Published: October 28, 2025

Impact of 2 years of treatment with elexacaftor/tezacaftor/ivacaftor on longitudinal changes in structural lung disease in people with cystic fibrosis: results from the RECOVER trial.

Impact of 2 years of treatment with elexacaftor/tezacaftor/ivacaftor on longitudinal changes in structural lung disease in people with cystic fibrosis: results from the RECOVER trial.

Journal: Annals of the American Thoracic Society

Published: August 11, 2025

Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population.

Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: July 31, 2025

Plant protein, fibre and physical activity solutions to address poor appetite and prevent undernutrition in older adults: study protocol for the APPETITE randomised controlled trial.

Plant protein, fibre and physical activity solutions to address poor appetite and prevent undernutrition in older adults: study protocol for the APPETITE randomised controlled trial.

Journal: The British journal of nutrition

Published: October 10, 2024

Real-world improvement in ultra-low-dose thoracic computed tomography scores, systemic inflammatory markers and patient-reported outcome measures after elexacaftor/tezacaftor/ivacaftor treatment.

Real-world improvement in ultra-low-dose thoracic computed tomography scores, systemic inflammatory markers and patient-reported outcome measures after elexacaftor/tezacaftor/ivacaftor treatment.

Journal: ERJ open research

Published: September 09, 2024

Experiences of Care for Adolescents With Mental Health Difficulties in Acute Paediatric Services: A Systematic Review.

Experiences of Care for Adolescents With Mental Health Difficulties in Acute Paediatric Services: A Systematic Review.

Journal: Journal of clinical nursing

Published: August 02, 2024

Caries in a cohort of adults with cystic fibrosis: a cross-sectional study.

Caries in a cohort of adults with cystic fibrosis: a cross-sectional study.

Journal: British dental journal

Published: July 18, 2024

Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study.

Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: April 25, 2024

The prevalence of developmental defects of enamel in a cohort of adults with cystic fibrosis - A cross sectional study.

The prevalence of developmental defects of enamel in a cohort of adults with cystic fibrosis - A cross sectional study.

Journal: Journal of dentistry

Published: October 12, 2023

Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Trial.

Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Trial.

Journal: American journal of respiratory and critical care medicine

Published: September 13, 2023

Periodontal disease prevalence and oral hygiene status of adults with cystic fibrosis: A case-control study.

Periodontal disease prevalence and oral hygiene status of adults with cystic fibrosis: A case-control study.

Journal: Journal of clinical periodontology

Published: May 08, 2023

The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6-11 with cystic fibrosis in a real-world setting.

The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6-11 with cystic fibrosis in a real-world setting.

Journal: Respiratory research

Published: February 13, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026